Skip to main content
. 2021 Apr 16;64(6):104227. doi: 10.1016/j.ejmg.2021.104227

Table 1.

Missense variants that might influence the acquisition or the course of COVID-19.

Gene name Protein name/Mim phenotype Reference SNP ID number Amino acid change Variant frequency GWAS p-value
ACE Angiotensin-converting enzyme rs3730025 Tyr244Cys 0.0107
AHSG Alpha-2-HS-glycoprotein
#203650
rs140827890 Ala164Thr 0.0114 0.05
CD27 CD27 antigen #615122 rs25680 Ala59Thr 0.1912
GFAP Glial fibrillary acidic protein
#203450
rs59291670 Asp157Asn 0.11
IFI30 Gamma-interferon-inducible lysosomal thiol reductase rs11554159 Arg76Gln 0.2281
MBL2 Mannose-binding protein C
#614372
rs1800450 Gly54Asp 0.141
rs5030737 Arg52Cys 0.0558
rs1800451 Gly57Glu 0.0318
MEFV Pyrin
#134610
#249100
rs3743930 Glu148Gln 0.0708
TLR2 Toll-like receptor 2
#607948
rs5743704 Pro631His 0.0281 0.02
rs5743708 Arg753Gln 0.0176
TLR3 Toll-like receptor 3
#609423
rs3775291 Leu412Phe 0.2789 0.03
TMPRSS2 Transmembrane protease serine 2 rs12329760 Val197Met 0.2452 0.01528

Table 1: Likely deleterious frequent variants (allele frequency >1%) in genes referable to the term “SARS-CoV*” in the literature. Variant frequency is referred to gnomAD total exome frequency obtained from wAnnovar annotation. For variants covered in the GWAS study, GCST90000255 Fisher p-values are provided.